Find Reports

Select Report Type

Reimbursement Review

Displaying 151 - 175 of 1426

Please scroll or swipe to the right to view the full content.

Title	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Prostate Cancer			Final Report	Prostate Cancer		Complete		Oct 27, 2023	PH0034-000
Chronic Lymphocytic Leukemia			Final Report	Chronic Lymphocytic Leukemia		Complete		Oct 27, 2023	PH0035-000
setmelanotide	Imcivree	setmelanotide	Recommendation and Reasons Clinical, Pharmacoeconomic, Ethics, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Bardet-Biedl syndrome	Reimburse with clinical criteria and/or conditions	Complete	Mar 7, 2023	Oct 16, 2023	SR0769-000
dupilumab	Dupixent	dupilumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Atopic dermatitis, pediatrics	Reimburse with clinical criteria and/or conditions	Complete	Mar 29, 2023	Oct 13, 2023	SR0774-000
nelarabine	Atriance	nelarabine	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	T-cell acute lymphoblastic leukemia	Reimburse with clinical criteria and/or conditions	Complete	Mar 6, 2023	Sep 29, 2023	PC0307-000
abiraterone acetate and predni...	n/a	abiraterone acetate and prednisolone	Recommendation and Reasons Stakeholder Input Stakeholder Feedback on Draft Recommendation Responses to Questions From the Drug Programs Clinical and Pharmacoeconomic Combined Report	High-risk non-metastatic prostate cancer	Reimburse with clinical criteria and/or conditions	Complete	Mar 23, 2022	Sep 8, 2023	PX0291-000 - PC0291-000
abiraterone, prednisone, docet...	N/A	abiraterone, prednisone, docetaxel	Recommendation and Reasons Responses to Questions From the Drug Programs Clinical and Pharmacoeconomic Combined Report Stakeholder Input Stakeholder Feedback on Draft Recommendation	Metastatic castration sensitive prostate cancer (mCSPC)	Reimburse	Complete	Jun 13, 2022	Sep 8, 2023	PX0298-000 - PC0298-000
upadacitinib	Rinvoq	upadacitinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Ulcerative colitis	Reimburse with clinical criteria and/or conditions	Complete	Apr 18, 2022	Sep 1, 2023	SR0730-000
tisagenlecleucel	Kymriah	tisagenlecleucel	Recommendation and Reasons Clinical, Pharmacoeconomic, Ethics, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Relapsed or refractory follicular lymphoma	Reimburse with clinical criteria and/or conditions	Complete	Feb 1, 2023	Sep 1, 2023	PG0306-000
zanubrutinib	Brukinsa	zanubrutinib	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Chronic lymphocytic leukemia /small lymphocytic lymphoma.	Reimburse with clinical criteria and/or conditions	Complete	Jan 20, 2023	Sep 1, 2023	PC0310-000
belzutifan	Welireg	belzutifan	Recommendation and Reasons Clinical, Pharmacoeconomic, Ethics, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	von Hippel-Lindau disease-associated tumours	Reimburse with clinical criteria and/or conditions	Complete	Jan 23, 2023	Sep 1, 2023	PC0309-000
cenobamate	Xcopri	cenobamate	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Epilepsy, partial-onset seizures	Reimburse with clinical criteria and/or conditions	Complete	Feb 7, 2023	Aug 29, 2023	SR0770-000
dapagliflozin	N/A	dapagliflozin	Recommendation and Reasons Responses to Questions From the Drug Programs Clinical and Pharmacoeconomic Combined Report Stakeholder Input Stakeholder Feedback on Draft Recommendation	Chronic kidney disease	Reimburse with clinical criteria and/or conditions	Complete	Jun 17, 2022	Aug 23, 2023	SX0749-000 - SR0749-000
roflumilast	Zoryve	roflumilast	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Plaque psoriasis	Reimburse with clinical criteria and/or conditions	Complete	Feb 2, 2023	Aug 16, 2023	SR0771-000
Non-Small Cell Lung Cancer wit...			Final Report	Non-Small Cell Lung Cancer without actionable oncogenic alterations		Complete		Aug 10, 2023	PH0029-000
avacopan	Tavneos	avacopan	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Antineutrophil cytoplasmic antibody-associated vasculitis	Do not reimburse	Complete	Oct 14, 2022	Aug 10, 2023	SR0732-000
cariprazine	Vraylar	cariprazine	Memorandum report to CADTH Response to the Procedural Review Panel’s Memorandum Report on the Procedural R…Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Schizophrenia	Do not reimburse	Complete	Oct 29, 2021	Aug 10, 2023	SR0708-000
ravulizumab	Ultomiris	ravulizumab	Recommendation and Reasons Clinical, Pharmacoeconomic and Ethics combined Report Stakeholder feedback on Draft Recommendation	AChR antibody-positive generalized Myasthenia Gravis	Do not reimburse	Complete	Oct 25, 2022	Aug 8, 2023	SR0765-000
deucravacitinib	Sotyktu	deucravacitinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Psoriasis, moderate to severe plaque	Do not reimburse	Complete	Sep 27, 2022	Aug 8, 2023	SR0756-000
Multiple Myeloma			Final Report	Multiple myeloma		Complete		Jul 27, 2023	PH0031-000
difelikefalin	Korsuva	difelikefalin	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Chronic kidney disease	Do not reimburse	Complete	Sep 22, 2022	Jul 13, 2023	SR0752-000
trastuzumab deruxtecan	Enhertu	trastuzumab deruxtecan	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	unresectable or metastatic HER2-low breast cancer	Reimburse with clinical criteria and/or conditions	Complete	Dec 13, 2022	Jun 29, 2023	PC0305-000
Adult B-Cell Precursor Acute L...			Final Report	Adult B-Cell Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative and Positive		Complete		Jun 28, 2023	PH0030-000
foslevodopa foscarbidopa	Vyalev	foslevodopa foscarbidopa	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Parkinson’s disease	Reimburse with clinical criteria and/or conditions	Complete	Nov 23, 2022	Jun 16, 2023	SR0768-000
Triple Negative Breast Cancer			Final Report	Triple Negative Breast Cancer		Complete		Jun 14, 2023	PH0024-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 151 - 175 of 602

Please scroll or swipe to the right to view the full content.

Title	Description	Files	Last Updated Sort ascending	Project Sub Line	Status	Project Number
Optimizing the Use of Iodinated Contrast Media: Conservation Strategies Used Across Canada During the 2022 Shortage		CM0001-ICM-Conservation-Strategies.pdf	Sep 20, 2023	CMII Service	Completed	CM0001-000
Direct-Acting Antivirals for Pediatric Chronic Hepatitis C Virus Infection		Direct-Acting Antivirals for Pediatric Chronic Hepatitis C Virus Infection	Sep 20, 2023	Rapid Review	Completed	RC1502-000
Midline and Extended Dwell Catheters for IV Antibiotics		Midline and Extended Dwell Catheters for IV Antibiotics	Sep 18, 2023	Rapid Review	Completed	RC1505-000
Non-Sterile Glove Use		Non-Sterile Glove Use	Sep 15, 2023	Rapid Review	Completed	RC1499-000
Somatropin for Short Stature		Somatropin for Short Stature	Sep 15, 2023	Rapid Review	Completed	RC1501-000
Remdesivir (Veklury) for the Treatment of COVID-19 in the Inpatient Setting		Summary Report — September 2023 Systematic Review — September 2023	Sep 13, 2023	Systematic Review	Completed	RE0048-000
Tocilizumab (Actemra) for the Treatment of Hospitalized Patients With COVID-19		Systematic Review — September 2023 Summary Report — September 2023	Sep 13, 2023	Systematic Review	Completed	RE0049-000
Nirmatrelvir-Ritonavir (Paxlovid) for the Treatment of COVID-19		Systematic Review, September 2023 Summary Report, September 2023	Sep 12, 2023	Health Technology Assessment	Completed	HT0042-000
Remdesivir (Veklury) for the Treatment of COVID-19 in the Outpatient Setting		Systematic Review — September 2023 Summary Report — September 2023	Sep 12, 2023	Health Technology Assessment	Completed	HT0041-000
Timing of Ventilator Circuit Tubing Replacement		Timing of Ventilator Circuit Tubing Replacement	Sep 8, 2023	Rapid Review	Completed	RC1498-000
Telephone Triage Services	Telephone triage programs provide timely access to trained health care professionals who can assess a patient’s symptoms over the phone and provide self-care advice or referral to an appropriate level of care.	canadian_telephone_triage_programs_infographic.pdf Telephone Triage Services	Sep 7, 2023	Environmental Scan	Completed	ES0378-000
Prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC)		Implementation Advice	Aug 30, 2023	Technology Review	Completed	HC0060-000
Transcatheter Edge-To-Edge Valve Repair for Tricuspid Regurgitation		Transcatheter Edge-To-Edge Valve Repair for Tricuspid Regurgitation	Aug 22, 2023	Rapid Review	Completed	RC1500-000
Utilization of Opioid Agonist Therapies in Canada		Utilization of Opioid Agonist Therapies in Canada	Aug 15, 2023	Technology Review	Completed	HC0064-000
Lipid Panel Screening for Adults Living With Chronic Conditions		Lipid Panel Screening for Adults Living With Chronic Conditions	Aug 10, 2023	Rapid Review	Completed	RC1497-000
Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytial Virus Outcomes in Infants		Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytia…	Aug 8, 2023	Technology Review	Complete	HE0044-000
Somatropin for Turner Syndrome		Somatropin for Turner Syndrome	Aug 4, 2023	Rapid Review	Completed	RC1493-000
Somatropin for Growth Hormone Deficiency		Somatropin for Growth Hormone Deficiency	Aug 4, 2023	Rapid Review	Completed	RC1492-000
At-Home Polysomnography Versus In-Clinic Polysomnography for Sleep Disorders		At-Home Polysomnography Versus In-Clinic Polysomnography for Sleep Disorders	Aug 4, 2023	Rapid Review	Completed	RC1495-000
Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation		Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation	Aug 1, 2023	Rapid Review	Completed	RC1496-000
Evidence Base for Virtual Primary Care		Evidence Base for Virtual Primary Care	Jul 31, 2023	Technology Review	Complete	HC0062-000
Virtual Care Rapid Scoping		Virtual Care Rapid Scoping: Main Report Virtual Care Rapid Scoping: Supporting Information Virtual Care Rapid Scoping: Summary Figures Evidence Map Virtual Care Rapid Scoping: Report Summary	Jul 31, 2023	Scoping Review	Completed	RE0041-000
Individuals’ Access to Medical Imaging Results via Patient Portals		Individuals’ Access to Medical Imaging Results via Patient Portals	Jul 31, 2023	CMII Service	Completed	CM0004-000
Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Upper Extremities		Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Upper Extremities	Jul 31, 2023	Rapid Review	Completed	RC1491-000
Platelet-Rich Plasma Injections for Lower Back Pain		Platelet-Rich Plasma Injections for Lower Back Pain	Jul 31, 2023	Rapid Review	Completed	RC1485-000

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 151 - 175 of 2138

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
osilodrostat		Mar 5, 2025	Reimbursement Review		Suspended	SR0804-000
risperidone		Mar 5, 2025	Reimbursement Review		Suspended	SR0811-000
masitinib mesylate		Mar 5, 2025	Reimbursement Review		Suspended	SR0766-000
Drug Shortages in Canada — Expert Panel		Mar 4, 2025	Health Technology Review	Technology Review	Completed	HC0074-000
Voice Prostheses and Heat-Moisture Exchangers for Adults following Total Laryngectomy	Draft Report - Version 2 Care for Adults Following Laryngectomy: Rapid Review Report Version 1	Mar 4, 2025	Health Technology Review	Rapid Review	Active	RC1551-000
Gastric cancer		Mar 3, 2025	Reimbursement Review	Provisional Funding Algorithm	Merged	PH0080-000
trifluridine and tipiracil	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Mar 3, 2025	Reimbursement Review		Complete	PC0330-000
Multiple Myeloma		Mar 3, 2025	Reimbursement Review	Provisional Funding Algorithm	Merged	PH0060-000
Crushed Buprenorphine-Naloxone Tablets	Crushed Buprenorphine-Naloxone Tablets	Feb 28, 2025	Health Technology Review	Rapid Review	Completed	RC1570-000
Pharmaceutical Reviews Update — Issue 54		Feb 27, 2025	Reimbursement Review	Pharmaceutical Review Update
Pharmaceutical Reviews Update — Issue 55		Feb 27, 2025	Reimbursement Review	Pharmaceutical Review Update
Endometrial cancer		Feb 27, 2025	Reimbursement Review	Provisional Funding Algorithm	Merged	PH0066-000
Urgent Care Centres		Feb 26, 2025	Health Technology Review	Environmental Scan	In Progress	ES0383-000
Subtalar Joint Arthroereisis	Subtalar Joint Arthroereisis	Feb 24, 2025	Health Technology Review	Rapid Review	Completed	RC1568-000
clindamycin plus benzoyl peroxide and adapalene	Recommendation and Reason Patient and Clinician Group input Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation	Feb 21, 2025	Reimbursement Review		Complete	SR0794-000
Multiple Myeloma	Proposed Scope	Feb 20, 2025	Reimbursement Review	Provisional Funding Algorithm	Open for Input	PH0086-000
Breast Cancer	Revised Proposed Scope	Feb 20, 2025	Reimbursement Review	Provisional Funding Algorithm	Active	PH0083-000
cabozantinib	Proposed Scope	Feb 20, 2025	Reimbursement Review		Active	PX0378-000
sotatercept	Recommendation and Reasons Patient and Clinician Group Input Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation	Feb 19, 2025	Reimbursement Review		Complete	SR0828-000
eplontersen	Recommendation and Reasons Patient and Clinician Group Input Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation	Feb 19, 2025	Reimbursement Review		Complete	SR0826-000
talazoparib		Feb 19, 2025	Reimbursement Review		Withdrawn	PC0316-000
pertuzumab	Proposed Scope	Feb 14, 2025	Reimbursement Review		Active	PX0379-000
trabectedin	Proposed Scope	Feb 14, 2025	Reimbursement Review		Active	PX0377-000
Melanoma	Proposed Scope	Feb 13, 2025	Reimbursement Review	Provisional Funding Algorithm	Open for Input	PH0072-000
burosumab	Recommendation and Reason Patient and Clinician Group input Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation	Feb 12, 2025	Reimbursement Review		Complete	SR0818-000

Provisional Funding Algorithm

Displaying 76 - 81 of 81